 Transplacental antiretroviral therapy adenine transgenic mice Transgenic mice provirus Moloney murine leukemia virus Mo-MuLV germ line infectious virus embryonic day ability adenine PMEA placenta embryos viremia model antiviral efficacy lack teratogenicity transplacental therapy zidovudine ZDV PMEA females daily intraperitoneal injection osmotic pump contrast ZDV PMEA noneffective viremia offspring embryotoxic dose specific toxic effects resorption pregnancy low birth weight neonatal death Histopathological analysis neonatal mice PMEA severe lymphoid depletion thymus PMEA therapy use pregnancy